Boston Scientific has announced a significant equity investment and sales and marketing agreement with Preventice Solutions. Boston Scientific will become the sole global sales and marketing representative for Preventice Solutions’ cardiology-related diagnostic and monitoring offerings.
Jon Otterstatter, president and chief global strategy officer, co-CEO, Preventice Solutions, says, “We are thrilled to partner with Boston Scientific and collaborate on additional areas of mutual commercial and strategic interest.”
“We will expand our service capability and build a foundation for a future in the management of remote patient care,” says John Untereker, executive vice president and chief operating officer, co-CEO, Preventice Solutions.
Preventice Solutions’ portfolio includes PatientCare Platform and the BodyGuardian range of products, including BodyGuardian Heart, BodyGuardian Verité and BodyGuardian Holter.